Funding for this research was provided by:
Patient-Centered Outcomes Research Institute (PCS-2017C2-7613)
National Center for Advancing Translational Sciences (UL1TR002538)
National Cancer Institute (P30CA042014)
Huntsman Cancer Foundation (NA)
Received: 18 December 2019
Accepted: 13 January 2020
First Online: 30 January 2020
Ethics approval and consent to participate
: The protocol for the study has been reviewed and approved by the University of Utah Institutional Review Board (#00111985).
: Not applicable.
: KK reports honoraria, consulting, sponsored research, or sponsored travel related to health information technology (IT) in the past 3 years with McKesson InterQual, Hitachi, Pfizer, Premier, Klesis Healthcare, RTI International, Vanderbilt University, the University of Washington, the University of California at San Francisco, the Mayo Clinic, the Association of American Medical Colleges, and the U.S. Office of the National Coordinator for Health IT (via ESAC, JBS International, A+ Government Solutions, Hausam Consulting, and Security Risk Solutions). KK is also an unpaid board member of the non-profit Health Level Seven International health IT standard development organization, and he has helped develop a number of health IT tools which may be commercialized to enable wider impact. None of these relationships have direct relevance to the manuscript but are reported in the interest of full disclosure.